Figure 4.

Adjusted odds ratio of being on ART among those in care, of being virologically suppressed among those on ART, and of being virologically suppressed among those with an available HIV RNA measurement, EuroSIDA study, 2014–2015 (n = 12,825)

ART: antiretroviral treatment.

Western Europe reference. Odds ratios are on a log2 scale. Virological suppression was defined as HIV RNA < 500 copies/mL. Total number of people excluded from analysis in panel C: n = 758 (7.6%).

^a Adjusted for current age, sex, risk group, CD4⁺ T-cells at entry into EuroSIDA, current hepatitis B status, current hepatitis status.